SecBot SecBot
8-K ·Filed Oct 6, 2026

SKIN

SkinHealth Systems Inc.
BULLISH
Impact 5/10
Horizonimmediate Processed21d 1h ago SEC0001628280-26-065232
8-K material event: Items 1.02
Actionable Insight ▲ Bullish

The full repayment of the convertible notes just before maturity removes a significant overhang — the notes could have converted into common stock, diluting existing shareholders. With the debt retired and the indenture discharged, the company's capital structure is cleaner. Monitor the next 10-Q for the impact on interest expense and cash position.

DirectionBullish
Confidencehigh
Horizonimmediate
Latest settled — T+5d
SKIN ▲ +1859.65% at T+5d
LONG call ✓ call won +1859.65% · α vs SPY +1860.63% · entry $0.5899 → $11.56
Next anchor: T+1d due 20d ago
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
Pending
due 20d ago
T+5d
+1859.65%
call +1859.65% · α +1860.63%
$11.56
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

SkinHealth Systems Inc. repaid the remaining $103.2 million principal of its 1.25% Convertible Senior Notes due 2026 in full on September 30, 2026, plus $645,218.75 in accrued interest, satisfying and discharging the indenture. This eliminates the company's last outstanding convertible debt obligation just before its October 1, 2026 maturity, removing future dilution risk and deleveraging the balance sheet.

Key Facts

  • Repaid remaining $103,235,000 aggregate principal of 1.25% Convertible Senior Notes due 2026
  • Paid $645,218.75 in accrued and unpaid interest
  • Indenture satisfied and discharged; company released from remaining obligations
  • Notes were originally issued September 14, 2021 and set to mature October 1, 2026
  • Repayment occurred on September 30, 2026, one day before scheduled maturity

Financial Impact

Debt repayment of $103.9 million total ($103.2M principal + $0.6M interest) eliminates the company's only outstanding convertible notes, removing potential equity dilution from conversion and reducing leverage

debtdilutioninterest expense

Risk Factors

  • The $103.9 million cash outlay may have meaningfully reduced the company's cash reserves; liquidity should be assessed in the next quarterly filing
  • No new financing or refinancing was disclosed — the company's ability to fund operations post-repayment depends on existing cash and operating cash flow

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-065232
Document: 0001628280-26-065232-index-headers.html0001628280-26-065232
Document: 0001628280-26-065232-index.html0001628280-26-065232
Document: 0001628280-26-065232.txt0001628280-26-065232
8 reports for SKIN
Performance horizon
Filters
Rows
Reports for SKIN — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$11.10awaiting T+5—$10.12 (−8.79%)
Oct 14, 2026
13d ago
8-K
NEUTRAL ★ 4/10
$11.56 $11.03▼ −4.58%▼ −5.04%$10.12 (−12.46%)
Oct 6, 2026
21d ago
8-K
BULLISH ★ 5/10
$0.5899 $11.56▲ +1859.65%▲ +1860.63%$10.12 (+1615.54%)
Jul 21, 2026
14w ago
Press Release
NEUTRAL ★ 1/10
$0.7616awaiting T+5—$10.12 (+1228.78%)
Jun 22, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$0.6668 $0.7126▲ +6.87%▲ +5.86%$10.12 (+1417.70%)
Apr 29, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$0.8040 $0.8990▲ +11.82%▲ +8.71%$10.12 (+1158.71%)
Apr 22, 2026
26w ago
8-K
NEUTRAL ★ 5/10
$0.8260 $0.8040▼ −2.66%▼ −4.14%$10.12 (+1125.18%)
Mar 12, 2026
32w ago
Press Release
MIXED ★ 6/10
$1.27 $1.13▼ −11.02%▼ −8.91%$10.12 (+696.85%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026